tradingkey.logo
tradingkey.logo
Search

Intensity Therapeutics: INVINCIBLE-4 TNBC Trial Update

ReutersSep 10, 2025 11:54 AM
facebooktwitterlinkedin

- Intensity Therapeutics Inc INTS.O:

  • INTENSITY THERAPEUTICS REPORTS INVINCIBLE-4, PRESURGICAL TRIPLE-NEGATIVE BREAST CANCER STUDY UPDATE

  • INTENSITY THERAPEUTICS INC - PATHOLOGICAL COMPLETE RESPONSE OBSERVED IN FIRST PATIENT OF COHORT A

  • INTENSITY THERAPEUTICS INC - LOCALIZED SKIN IRRITATION OBSERVED, NEW PATIENT ENROLLMENT PAUSED

  • INTENSITY THERAPEUTICS INC - SIGNIFICANT NECROSIS OBSERVED AFTER TWO DOSES OF INT230-6

  • INTENSITY THERAPEUTICS INC - SAFETY LOOKS FAVORABLE IN COHORT A

  • INTENSITY THERAPEUTICS INC - EXPECT TO REINITIATE ENROLLMENT WITH MODIFIED INT230-6 DOSING REGIMEN AS SOON AS POSSIBLE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI